Google
×
Mar 20, 2008 · Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and ...
Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow ...
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow ...
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow ...
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow ...
Nov 16, 2006 · Initiated by the European Group for Blood and Marrow Transplantation, this study observed pts. ... receiving high dose melphalan or BEAM ...
Request PDF | Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood ...
Nov 8, 2012 · ... dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group. Blijlevens, Nicole and ...
Jan 9, 2017 · Obese patients have ... melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Jan 1, 2009 · ... patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT ... BLOOD, PALIFERMIN, INFECTION, DELIVERY, THERAPY, ...